Stage I Prostate Adenocarcinoma
specificStage I includes: (T1a-c, N0, M0, PSA less than 10, Gleason equal or less than 6); (T2a, N0, M0, PSA less than 10, Gleason equal or less than 6); (T1-2a, N0, M0, PSA X, Gleason X). T1a: Tumor incidental histologic finding in 5% or less of tissue resected. T1b: Tumor incidental histologic finding in more than 5% of tissue resected. T1c: Tumor identified by needle biopsy (e.g., because of elevated PSA). T2a: Tumor involves one-half of one lobe or less. cN0: No regional lymph node metastasis.
3
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Stage I Prostate Adenocarcinoma(3)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive | 66.7 |
| 2 | University of Illinois Cancer CenterChicago, IL | 66.7 |
| 3 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 66.7 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →